Seaport Therapeutics, Inc. — Form D

Seaport Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-31. The offering totals $226.0M, of which $225.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-10-31
Form: D
Accession: 0002042347-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $226.0M
Amount sold: $225.9M
Remaining: $100K
Investors: 33
Date of first sale: 2024-10-18
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-528276

Issuer

Name: Seaport Therapeutics, Inc.
CIK: 0002042347
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2024
Address: 6 TIDE STREET, BOSTON, MA, 02110
Phone: 617-807-4062

Officers, directors & promoters (14)

Name	Role	Location
Bharatt I Chowrira	Director	Boston, MA
Eric Elenko	Director	Boston, MA
James I Healy	Director	DORADO, PR
Robert I Nelsen	Director	Boston, MA
Steven Paul	Director	Boston, MA
Jason I Pitts	Director	Boston, MA
Denice I Torres	Director	Boston, MA
David I Wheadon	Director	Boston, MA
Daphne Zohar	Director	Boston, MA
Michael Chen	Executive Officer	Palm Springs, CA
Lana Gladstein	Executive Officer	Boston, MA
Eric Green	Executive Officer	Miami, FL
Antony Loebel	Executive Officer	Boston, MA
Daphne Zohar	Executive Officer	Boston, MA

More